Serge Saxonov: Thanks, Cassie, and good afternoon, everyone. What a really nice start to the year, with solid sales momentum, a step-change advance in our product roadmap, and strong execution across the business. Revenue for the first quarter was $151 million, representing 9% growth over Q1 2025 when excluding the nonrecurring settlement revenue in the prior-year period. In single cell, we again saw double-digit growth in consumable reaction volumes, driven by FLEX and FLEX Apex. As we have been seeing ove ...